Senior Scientist, PET Radiochemist at Johnson & Johnson

San Diego, California, United States

Johnson & Johnson Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Healthcare, BiotechnologyIndustries

Requirements

  • Bachelor's degree in Chemistry or a related field with 6+ years of industry experience (required); Master's with 4+ years or PhD with 2+ years post-doctoral or industry experience highly preferred
  • Experience in radiochemistry and imaging probe development (required)
  • Confirmed expertise in radiolabeling both small and large molecule PET tracers (preferred)
  • Proficiency with radioisotopes such as F-18, Cu-64, Ga-68, and Zr-89 (required)
  • Familiarity with automated PET synthesis modules (preferred)
  • Knowledge of radiation safety principles and health physics (required)
  • Industry experience (advantageous, but not required)

Responsibilities

  • Radiolabeling small and large lead molecules with PET and SPECT imaging isotopes
  • Proactively investigating and optimizing existing radiosynthetic processes or developing new, improved methods
  • Synthesizing precursors and standards in a chemistry lab on an ad hoc basis as needed
  • Generating independent hypotheses based on synthesis and design data; completing follow-up experiments, purifications, and analyses with minimal supervision
  • Reviewing and improving standard procedures to enhance current approaches
  • Drafting and submitting peer-reviewed manuscripts, technical reports, and patent applications
  • Independently planning, completing, and troubleshooting experiments; documenting data; interpreting results; and communicating findings optimally
  • Collaborating with global therapeutic areas, external partners, academic institutions, and CROs to support imaging studies and develop novel imaging biomarkers

Skills

PET Radiochemistry
SPECT Radiochemistry
Radiolabeling
Radiosynthesis
Radiochemical Optimization
Isotope Handling
Chemical Research

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters
1886Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.
Former J&J executives joining other firms could lead to increased competition.
Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.
The company invests heavily in R&D for innovative medical solutions and products.
J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.
The rise of personalized medicine offers J&J opportunities in targeted therapies.
Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI